Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urokinase in Diabetic Foot Syndrome and Critical Limb Ischemia
NCT01638585Phase 3Terminated
- Sponsor
- GWT-TUD
- Start
- Jun 2011
- Primary completion
- Nov 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of urokinase in diabetic foot syndrome, critical limb ischemia (CLI), sponsored by GWT-TUD. Started Jun 2011; status: terminated.
02
Drugs
urokinase
03
Conditions
diabetic foot syndromecritical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01638585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638585.